D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.14% |
| 2 | Financials | 9.37% |
| 3 | Healthcare | 7.49% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EB
3426
DELISTED
Eventbrite
EB
| $1.02M | ﹤0.01% |
168,663
-20,581
| -11% | -$173K |
|
3427
NewMarket
NEU
$7.24B
| $1.02M | ﹤0.01% |
3,404
+1,632
| +92% | +$489K |
|
3428
Linde
LIN
$236B
| $1.02M | ﹤0.01% |
3,787
+787
| +26% | +$226K |
|
3429
Pacific Biosciences
PACB
$435M
| $1.02M | ﹤0.01% |
175,861
-2,222,426
| -93% | -$12.8M |
|
3430
Molina Healthcare
MOH
$10.4B
| $1.01M | ﹤0.01% |
3,075
-12,837
| -81% | -$4.13M |
|
|
EMCGU
3431
DELISTED
Embrace Change Acquisition Corp Unit
EMCGU
| $1.01M | ﹤0.01% |
+100,000
| New | +$1.01M |
|
|
API
3432
Agora
API
$333M
| $1.01M | ﹤0.01% |
278,720
+176,667
| +173% | +$836K |
|
|
FTCV
3433
DELISTED
FinTech Acquisition Corp. V Class A Common Stock
FTCV
| $1.01M | ﹤0.01% |
+101,553
| New | +$1.01M |
|
3434
Fulgent Genetics
FLGT
$558M
| $1.01M | ﹤0.01% |
26,470
+5,870
| +28% | +$294K |
|
3435
CALL
QuantumScape Corp
QS
$3.05B
| $1.01M | ﹤0.01% |
120,000
+31,700
| +36% | +$340K |
|
|
CHEA
3436
DELISTED
Chenghe Acquisition Co. Class A Ordinary Share
CHEA
| $1.01M | ﹤0.01% |
100,000
+33,333
| +50% | +$335K |
|
3437
RadNet
RDNT
$4.98B
| $1M | ﹤0.01% |
49,317
+8,044
| +19% | +$162K |
|
3438
Twist Bioscience
TWST
$5.32B
| $1M | ﹤0.01% |
28,484
-74,653
| -72% | -$3.17M |
|
3439
CALL
Freshpet
FRPT
$3.04B
| $1M | ﹤0.01% |
+20,000
| New | +$943K |
|
3440
CALL
BHP
BHP
$211B
| $1M | ﹤0.01% |
20,000
-30,000
| -60% | -$1.59M |
|
3441
PUT
Kraft Heinz
KHC
$32.8B
| $1M | ﹤0.01% |
+30,000
| New | +$1.11M |
|
3442
Wintrust Financial
WTFC
$10.7B
| $998K | ﹤0.01% |
12,232
+7,137
| +140% | +$606K |
|
|
DISA
3443
DELISTED
Disruptive Acquisition Corporation I Class A Ordinary Shares
DISA
| $995K | ﹤0.01% |
100,100
-966,792
| -91% | -$9.53M |
|
|
PV
3444
DELISTED
Primavera Capital Acquisition Corporation
PV
| $995K | ﹤0.01% |
100,000
-1,374,174
| -93% | -$13.6M |
|
|
MVLA
3445
DELISTED
Movella Holdings Inc. Common Stock
MVLA
| $994K | ﹤0.01% |
100,000
-1,054,800
| -91% | -$10.4M |
|
|
SCOB
3446
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
| $994K | ﹤0.01% |
100,000
-856,574
| -90% | -$8.45M |
|
3447
Cullinan Oncology
CGEM
$1.06B
| $993K | ﹤0.01% |
77,440
-17,546
| -18% | -$236K |
|
3448
La-Z-Boy
LZB
$1.64B
| $993K | ﹤0.01% |
43,975
+22,981
| +109% | +$610K |
|
|
VBOC
3449
DELISTED
Viscogliosi Brothers Acquisition Corp Common Stock
VBOC
| $991K | ﹤0.01% |
100,450
| – | – |
|
3450
Banco Macro
BMA
$5.81B
| $990K | ﹤0.01% |
+69,397
| New | +$937K |
|
Similar funds
D.E. Shaw & Co's Q3 2022 Portfolio in Review
As of Q3 2022, D.E. Shaw & Co held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
D.E. Shaw & Co withdrew a net $3.66B in Q3 2022, closing 679 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Prologis worth $66.1M.
- D.E. Shaw & Co's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- D.E. Shaw & Co added most to Visa in Q3 2022, an estimated $365M increase.
- D.E. Shaw & Co's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- D.E. Shaw & Co fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- D.E. Shaw & Co's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- D.E. Shaw & Co opened 545 new positions and closed 679 in Q3 2022.
- D.E. Shaw & Co's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.